CLARITY Extension Study (Q61914816)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CLARITY Extension Study |
clinical trial |
Statements
A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects With Relapsing-Remitting Multiple Sclerosis Who Have Completed Trial 25643 (CLARITY) (English)
0 references
February 2008
0 references
December 2011
0 references
867
0 references
18 year
0 references
65 year
0 references